Evidence map›Paper›PMID 33535182›Full record

ArticleAging2021

LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis.

Jinlan Guo, Quan Gan, Caibin Gan, Xiaoning Zhang, Xinping Ma, Mingliang Dong

Abstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Frontiers in cell and developmental biology · 2022
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jinlan GuoXinxiang Central Hospital, Xinxiang 453000, Henan, China.
Quan GanXinxiang Central Hospital, Xinxiang 453000, Henan, China.
Caibin GanXinxiang Central Hospital, Xinxiang 453000, Henan, China.
Xiaoning ZhangXinxiang Central Hospital, Xinxiang 453000, Henan, China.
Xinping MaXinxiang Central Hospital, Xinxiang 453000, Henan, China.
Mingliang DongXinxiang Central Hospital, Xinxiang 453000, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we investigated the role of lncRNA MIR205HG in melanomagenesis. Quantitative real-time PCR (qRT-PCR) analysis showed that MIR205HG levels were significantly upregulated in melanoma cell lines compared to normal human melanocytes. Similarly, MIR205HG levels were significantly higher melanoma tissues than adjacent normal skin tissues (n=30). CCK-8 and flow cytometry assays showed that MIR205HG knockdown significantly decreased the viability of melanoma cells. Dual luciferase reporter and RNA pull-down assays confirmed that MIR205HG directly binds to microRNA (miR)-299-3p. Targetscan analysis and dual luciferase reporter assays showed that miR-299-3p directly binds to the 3'UTR of VEGFA mRNA. Wound healing and transwell invasion assays showed that MIR205HG knockdown decreased

Indexed as

AnimalsApoptosisCarcinogenesisCell Line, TumorGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansMelanocytesMelanomaMiceMice, NudeMicroRNAsRNA, Long NoncodingSkin NeoplasmsVascular Endothelial Growth Factor AMicroRNAsMIRN299 microRNA, humanRNA, Long NoncodingVascular Endothelial Growth Factor AmelanomaMIR205HGmiR-299-3pVEGFA

Identifiers

PMID33535182
PMCPMC7950277

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.